↓ Skip to main content

Intravenous immunoglobulin for myasthenia gravis

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
92 Dimensions

Readers on

mendeley
158 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravenous immunoglobulin for myasthenia gravis
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd002277.pub4
Pubmed ID
Authors

Philippe Gajdos, Sylvie Chevret, Klaus V Toyka

Abstract

Myasthenia gravis is an autoimmune disease in which autoantibodies interfere with neuromuscular transmission. As with other autoimmune diseases, people with myasthenia gravis would be expected to benefit from intravenous immunoglobulin (IVIg). This is an update of a review first published in 2003 and last updated in 2007.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 158 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 1%
Spain 2 1%
Colombia 1 <1%
United Kingdom 1 <1%
Unknown 152 96%

Demographic breakdown

Readers by professional status Count As %
Other 22 14%
Student > Master 21 13%
Student > Bachelor 20 13%
Student > Doctoral Student 18 11%
Researcher 17 11%
Other 43 27%
Unknown 17 11%
Readers by discipline Count As %
Medicine and Dentistry 89 56%
Nursing and Health Professions 11 7%
Agricultural and Biological Sciences 9 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Biochemistry, Genetics and Molecular Biology 5 3%
Other 17 11%
Unknown 20 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2019.
All research outputs
#9,250,505
of 14,684,909 outputs
Outputs from Cochrane database of systematic reviews
#9,366
of 11,037 outputs
Outputs of similar age
#139,275
of 254,063 outputs
Outputs of similar age from Cochrane database of systematic reviews
#445
of 510 outputs
Altmetric has tracked 14,684,909 research outputs across all sources so far. This one is in the 24th percentile – i.e., 24% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,037 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.5. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 254,063 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 510 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.